We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

13 hedge funds and large institutions have $747K invested in Eterna Therapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more funds holding

Funds holding: 11 → 13 (+2)

5% more capital invested

Capital invested by funds: $712K → $747K (+$34.5K)

0.02% more ownership

Funds ownership: 0.02% → 0.04% (+0.02%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Corient Private Wealth
Corient Private Wealth
Florida
+$363K
2
UBS Group
UBS Group
Switzerland
+$143K
3
TSS
Two Sigma Securities
New York
+$56.3K

Top Sellers

Rank Fund Capital Flow
1
SCA
Sippican Capital Advisors
Massachusetts
-$7.04K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$5.76K
3
TRCT
Tower Research Capital (TRC)
New York
-$640
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
Corient Private Wealth
1
Corient Private Wealth
Florida
$276K +$363K +567 +423%
CPWM
2
Cypress Point Wealth Management
Texas
$99.1K – – –
UBS Group
3
UBS Group
Switzerland
$87.8K +$143K +223 New
NW
4
Naviter Wealth
Arkansas
$82.7K – – –
SCA
5
Sippican Capital Advisors
Massachusetts
$71.9K -$7.04K -11 -6%
TSS
6
Two Sigma Securities
New York
$34.5K +$56.3K +88 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$27.4K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$21.5K -$5.76K -9 -14%
BlackRock
9
BlackRock
New York
$15.7K – – –
AWE
10
Avidian Wealth Enterprises
Texas
$15.5K – – –
BWP
11
Baldwin Wealth Partners
Massachusetts
$8.97K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$5.24K -$640 -1 -7%
MA
13
Montag & Associates
Georgia
$223 – – –
Bank of America
14
Bank of America
North Carolina
$129 – – –
AWM
15
Activest Wealth Management
Florida
$53 – – –
Morgan Stanley
16
Morgan Stanley
New York
$53 – – –
Group One Trading
17
Group One Trading
Illinois
$20 – – –
Citigroup
18
Citigroup
New York
$16 – – –
JP Morgan Chase
19
JP Morgan Chase
New York
$15 – – –
APC
20
Aspire Private Capital
North Carolina
$11 – – –
Qube Research & Technologies (QRT)
21
Qube Research & Technologies (QRT)
United Kingdom
– -$8 – –

ERNA Hedge Fund Activity: Q3 2024 in Review

13 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q3 2024, worth a combined $747K — up 4.8% from $712K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ERNA positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Corient Private Wealth, adding an estimated $363K. The largest seller was Sippican Capital Advisors, cutting an estimated $7.04K.

  • 13 institutional investors held Eterna Therapeutics (ERNA) as of Q3 2024, up from 11 in Q2 2024.
  • Funds reported $747K of Eterna Therapeutics stock for Q3 2024, up 4.8% quarter-over-quarter.
  • 2 funds opened new Eterna Therapeutics positions in Q3 2024 and 0 closed out, a net change of +2 holders.
  • The largest Eterna Therapeutics buyer in Q3 2024 was Corient Private Wealth, an estimated $363K added.
  • The largest Eterna Therapeutics seller in Q3 2024 was Sippican Capital Advisors, an estimated $7.04K sold.

Based on aggregated 13F filings for Q3 2024.